Moutih Rafei
Chief Tech/Sci/R&D Officer presso DEFENCE THERAPEUTICS INC.
Patrimonio netto: 87 500 $ in data 31/03/2024
Profilo
Moutih Rafei is the founder of Axiom Services, Inc., IntelliStem Technologies, Inc. He is currently working as the Chief Scientific Officer & Director at Defence Therapeutics Inc. Additionally, he holds the position of Professor & Principal Investigator at the University of Montréal.
Dr. Rafei obtained his doctorate degree from McGill University in 2009.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
02/11/2023 | 70 000 ( 0.16% ) | 87 500 $ | 31/03/2024 |
Posizioni attive di Moutih Rafei
Società | Posizione | Inizio |
---|---|---|
DEFENCE THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 09/10/2020 |
University of Montréal | Corporate Officer/Principal | - |
Precedenti posizioni note di Moutih Rafei
Società | Posizione | Fine |
---|---|---|
IntelliStem Technologies, Inc.
IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Founder | 01/08/2023 |
Formazione di Moutih Rafei
McGill University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
DEFENCE THERAPEUTICS INC. | Health Technology |
Aziende private | 1 |
---|---|
IntelliStem Technologies, Inc.
IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Moutih Rafei